2nd Quarter - Report

NATIONAL PSORIASIS FOUNDATION for NATIONAL PSORIASIS FOUNDATION

Firm
Client
Income
—
Expenses
$130,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

1. Urge Congress to support efforts that increase access to care for people with psoriasis and psoriasis arthritis by supporting H.R.1600: Patients' Access to Treatments Act of 2015. This bill limits copayments, coinsurance, and other costsharing and out-of-pocket expenses for so called specialty tier drugs. This bill will help ensure that people with psoriasis and other chronic conditions have access to the therapy that their health care provider determines is most appropriate for them. 2. Support efforts to facilitate research efforts on psoriasis and psoriatic arthritis within institutes at the NIH. 3. Urge Congress to support HR 6, the 21st Century Cures Act. 4. Working with the CDC's National Center for Health Statistics, a division of the CDC, to better understand the current and looming data on psoriasis and psoriatic arthritis held by the NCHS to inform our research agenda.

LobbyistCovered position, as disclosed
QUARDRICOS BERNARD DRISKELL —
LEAH MCCORMICK HOWARD —
SARA KOFMAN —

Contacted: Centers For Disease Control & Prevention (CDC); SENATE; Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES

Bills named: H.R. 1600 (114th), H.R. 6 (114th)

Budget/Appropriations BUD

FY16 Appropriations for Psoriatic Disease Allocate $1.2 million in the Fiscal Year (FY) 2014 Labor, Health and Human Services, Education and Related Agencies (LHHS) Appropriations bill to implement a public health agenda for psoriasis and psoriatic arthritis at the Centers for Disease Control and Prevention (CDC). With this funding, the CDCs National Center for Health Statistics (NCHS) could begin implementation of the first ever psoriasis and psoriatic arthritis public health agenda by developing survey instruments, which will: Increase the understanding of psoriasis, including the prevalence of the diseases and how age, sex, race, and ethnicity affect the course and burden of psoriasis; Study how differences in genetic and nongenetic factors, such as environmental exposure and lifestyle,contribute to the occurrence and severity of psoriasis and psoriatic arthritis; Examine the relationship of psoriasis to other serious diseases and develop public health strategies to reduce the burden of diseases and prevent the onset of comorbid conditions; and Gain insight into the longtermimpact of psoriasis and psoriatic arthritis.

LobbyistCovered position, as disclosed
QUARDRICOS BERNARD DRISKELL —
LEAH MCCORMICK HOWARD —
SARA KOFMAN —

Contacted: HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); SENATE; Centers For Disease Control & Prevention (CDC)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.